Have a personal or library account? Click to login
Potential New Approaches for Prostate Cancer Management in Resource-Limited Countries in Africa Cover

Potential New Approaches for Prostate Cancer Management in Resource-Limited Countries in Africa

Annals of Global Health
Volume 89 (2023): Issue 1
By: Maarten C. Bosland,  Olayiwola B. Shittu,  Edet E. Ikpi and  Oluyemi Akinloye  
Open Access
|Feb 2023

References

  1. 1Bray F, Parkin DM. African Cancer Registry Network: Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs. Lancet Oncology. 2022; 23: 719–728. DOI: 10.1016/S1470-2045(22)00270-4
    Back to article
  2. 2Bosland MC, Nettey OS, Phillips AA, et al. Prevalence of prostate cancer at autopsy in Nigeria- A preliminary report. Prostate. 2021; 81: 553–559. DOI: 10.1002/pros.24133
    Back to article
  3. 3Bukirwa P, Wabinga H, Nambooze S, et al. Trends in the incidence of cancer in Kampala, Uganda, 1991 to 2015. International Journal of Cancer. 2021; 148: 2129–2138. DOI: 10.1002/ijc.33373
    Back to article
  4. 4Parkin DM, Chingonzoh T, Vuma S, et al. Changes in the Incidence of Cancer in Bulawayo, Zimbabwe over a 50-Year Period. Cancer Epidemiology, Biomarkers & Prevention. 2021; 30: 867–873. DOI: 10.1158/1055-9965.EPI-20-0669
    Back to article
  5. 5Seraphin TP, Joko-Fru WY, Kamaté B, et al. Rising prostate cancer incidence in sub-Saharan Africa: A trend analysis of data from the African Cancer Registry Network. Cancer Epidemiology, Biomarkers & Prevention. 2021; 30: 158–165. DOI: 10.1158/1055-9965.EPI-20-1005
    Back to article
  6. 6Albertsen PC. PSA testing, cancer treatment, and prostate cancer mortality reduction: What is the mechanism? Urologic Oncology. 2021 Sep 6; S1078–1439(21): 00369–0.
    Back to article
  7. 7Fenton JJ, Weyrich MS, Durbin S, et al. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018; 319: 1914–1931. DOI: 10.1001/jama.2018.3712
    Back to article
  8. 8Makau-Barasa LK, Manirakiza A, Carvalho AL, et al. Prostate Cancer Screening, Diagnostic, Treatment Procedures and Costs in Sub-Saharan Africa: A Situational Analysis. Cancer Control. 2022; 29: 10732748221084932. DOI: 10.1177/10732748221084932
    Back to article
  9. 9Ikuerowo SO, Omisanjo OA, Bioku MJ, et al. Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination. Pan African Medical Journal. 2013; 15: 129. DOI: 10.11604/pamj.2013.15.129.2489
    Back to article
  10. 10Ogundele SO, Ikuerowo SO. A Survey of the Awareness of Prostate Cancer and its Screening among Men Attending the Outpatient Clinics of a Tertiary Health Center in Lagos, Nigeria. Nigerian Journal of Surgery. 2015; 21: 115–118. DOI: 10.4103/1117-6806.162589
    Back to article
  11. 11Asare BY, Ackumey MM. Awareness and knowledge about prostate cancer among male teachers in the Sunyani Municipality, Ghana. African Health Sciences. 2021 Jun; 21(2): 655–662. DOI: 10.4314/ahs.v21i2.22
    Back to article
  12. 12Meka IA, Okwor CJ, Arum EJ, et al. Evaluation of prostate-specific antigen testing: An empirical survey of laboratories in Nigerian tertiary care centers. International Journal of Medicine and Health Development. 2022; 27: 233–237. DOI: 10.4103/ijmh.IJMH_8_22
    Back to article
  13. 13Oranusi CK, Ugezu AI, Nwofor A. Diagnosis of prostate cancer with needle biopsy: should all cases be biopsied before treatment? Nigerian Journal of Clinical Practice. 2012; 15: 48–50. DOI: 10.4103/1119-3077.94097
    Back to article
  14. 14OECD. Africa’s Urbanization Dynamics; 2020. https://www.oecd.org/development/africa-s-urbanisation-dynamics-2020-b6bccb81-en.htm.
    Back to article
  15. 15Kaboré FA, Zango B, Kambou T, et al. Prostate cancer disease characteristics at the time of diagnosis and initial treatment offered in a tertiary hospital at Ouagadougou (Burkina Faso). Open Journal of Urology. 2014; 4: 7–12. DOI: 10.4236/oju.2014.41002
    Back to article
  16. 16Tolani MA, Khalifa AI, Afolayan AO. Clinicopathological characteristics of benign prostatic hyperplasia and prostate cancer in a University Teaching Hospital in Nigeria. Annals of Tropical Pathology. 2020; 11: 56–60. DOI: 10.4103/atp.atp_18_20
    Back to article
  17. 17Seraphin TP, Joko-Fru WY, Hämmerl L. Presentation, patterns of care, and outcomes of patients with prostate cancer in sub-Saharan Africa: A population-based registry study. Cancer. 2021; 127: 4221–4232. DOI: 10.1002/cncr.33818
    Back to article
  18. 18Amin SM, Jibrin PG, Olah FG, et al. Clinicopathological analysis of prostatic lesions in a tertiary hospital in Nigeria. Annals of Tropical Pathology. 2020; 11: 25–28. DOI: 10.4103/atp.atp_14_19
    Back to article
  19. 19Agalliu I, Adebiyi AO, Lounsbury DW, et al. The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria. BMC Public Health. 2015; 15: 425. DOI: 10.1186/s12889-015-1754-x
    Back to article
  20. 20Ugwumba FO, Nnabugwu II. Prostate cancer characteristics: A descriptive analysis of clinical features at presentation in the last decade in a black African community. Annals of African Medicine. 2022; 21: 153–157. DOI: 10.4103/aam.aam_101_20
    Back to article
  21. 21Khauli R, Ferrigno R, Guimarães G, et al. Treatment of localized and locally advanced, high-risk prostate cancer: A report from the First Prostate Cancer Consensus Conference for Developing Countries. JCO Global Oncology. 2021; 7: 530–537. DOI: 10.1200/GO.20.00421
    Back to article
  22. 22Yamoah K, Beecham K, Hegarty SE, et al. Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes. BMC Cancer. 2013; 13: 23. DOI: 10.1186/1471-2407-13-23
    Back to article
  23. 23Cassell A, Yunusa B, Jalloh M, et al. A review of localized prostate cancer: an African perspective. World Journal of Oncology. 2019; 10: 162–168. DOI: 10.14740/wjon1221
    Back to article
  24. 24Index-Mundi. 2022. https://www.indexmundi.com/g/r.aspx?v=69.
    Back to article
  25. 25Central Intelligence Agency. The CIA World Factbook 2020–2021. New York, NY: Skyhorse Publishing. 2020.
    Back to article
  26. 26Adedeji IA, Lawal SA, Aluko-Arowolo S. Prostate cancer knowledge gaps among community stakeholders in rural Nigeria: implications for seeking screening. Cancer Causes Control. 2021; 32: 895–901. DOI: 10.1007/s10552-021-01444-y
    Back to article
  27. 27Kyei MY, Klufio GO, Ayamba A, et al. Traditional medicines and alternative practice in the management of prostate diseases in southern Ghana. Ghana Medical Journal. 2017; 51: 128–137. DOI: 10.4314/gmj.v51i3.6
    Back to article
  28. 28Mwaka AD, Abbo C, Kinengyere AA. Traditional and Complementary Medicine Use Among Adult Cancer Patients Undergoing Conventional Treatment in Sub-Saharan Africa: A Scoping Review on the Use, Safety and Risks. Cancer Management and Research. 2020; 12: 3699–3712. DOI: 10.2147/CMAR.S251975
    Back to article
  29. 29Madersbacher S, Mian C, Maier U, et al. Validation of a 10-minute dipstick test for serum prostate-specific antigen. European Urology. 1996; 30: 446–450. DOI: 10.1159/000474213
    Back to article
  30. 30Ashida S, Yamasaki I, Kawada C, et al. Evaluation of a rapid one-step PSA test for primary prostate cancer screening. BMC Urology. 2021; 21: 135. DOI: 10.1186/s12894-021-00903-7
    Back to article
  31. 31Heyns CF, Naudé AM, Ahmed G, et al. Serum prostate-specific antigen as surrogate for the histological diagnosis of prostate cancer. South African Medical Journal. 2001; 91: 685–689.
    Back to article
  32. 32Heyns CF, Basson J, Van der Merwe A, et al. Clinical (non-histological) diagnosis of advanced prostate cancer: Evaluation of treatment outcome after androgen deprivation therapy. South African Journal of Surgery. 2014; 52: 82–85. DOI: 10.7196/sajs.1689
    Back to article
  33. 33Liao KM, Wang YL, Chen CY. Medication utilization evaluation of androgen deprivation therapy for prostate cancer in Taiwan. Medicine (Baltimore). 2020; 99: e23644. DOI: 10.1097/MD.0000000000023644
    Back to article
  34. 34Magoha GA. Management and survival in advanced prostate cancer in Nairobi. East African Medical Journal. 2000; 77: 260–263. DOI: 10.4314/eamj.v77i5.46630
    Back to article
  35. 35Chen XQ, Huang Y, Li X, et al. Efficacy of maximal androgen blockade versus castration alone in the treatment of advanced prostate cancer: a retrospective clinical experience from a Chinese medical centre. Asian Journal of Andrology. 2010; 12: 718–727. DOI: 10.1038/aja.2010.42
    Back to article
  36. 36Weiner AB, Cohen JE, DeLancey JO, et al. Surgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort. Journal of Urology. 2020; 203: 933–939. DOI: 10.1097/JU.0000000000000684
    Back to article
  37. 37Orakwe DE, Tijani KH, Jeje EA, et al. Bilateral subcapsular orchiectomy versus bilateral total orchiectomy: Comparison of the quality of life post-orchiectomy. Nigerian Postgraduate Medical Journal. 2018; 25: 43–47. DOI: 10.4103/npmj.npmj_169_17
    Back to article
  38. 38Chibuzo INC, Takure AO, Shittu OB, et al. Cosmetic Appeal, HRQoL, and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer. Prostate Cancer. 2021; 2021: 9968570. DOI: 10.1155/2021/9968570
    Back to article
  39. 39Berry W, Dakhil S, Modiano M, et al. Phase III study of mitoxantrone plus low dose prednisone versus low dose prednisone alone in patients with asymptomatic hormone refractory prostate cancer. Journal of Urology. 2002; 168: 2439–2443. DOI: 10.1016/S0022-5347(05)64163-8
    Back to article
  40. 40Kendig CE, Samuel JC, Tyson AF, et al. Cancer Treatment in Malawi: A Disease of Palliation. World Journal of Oncology. 2013; 4: 142–146. DOI: 10.4021/wjon683w
    Back to article
  41. 41Cassell A, Yunusa B, Jalloh M, et al. Management of Advanced and Metastatic Prostate Cancer: A Need for a Sub-Saharan Guideline. Journal of Oncology. 2019; 2019: 1785428. DOI: 10.1155/2019/1785428
    Back to article
  42. 42Mbugua RG, Karanja S, Oluchina S. Effectiveness of a Community Health Worker-Led Intervention on Knowledge, Perception, and Prostate Cancer Screening among Men in Rural Kenya. Advances in Preventative Medicine. 2022; 2022: 4621446. DOI: 10.1155/2022/4621446
    Back to article
DOI: https://doi.org/10.5334/aogh.3994 | Journal eISSN: 2214-9996
Journal RSS Feed
Language: English
Submitted on: Oct 23, 2022
Accepted on: Feb 27, 2023
Published on: Feb 20, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Prostate cancer,
Prostate-specific antigen,
Sub-Shaharan Africa,
Treatment alternatives,
Hormonal therapy,
Low resource areas

© 2023 Maarten C. Bosland, Olayiwola B. Shittu, Edet E. Ikpi, Oluyemi Akinloye, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 89 (2023): Issue 1Next article